Ida Vind

Ida Vind serves as a Clinical Associate Professor within the Department of Clinical Medicine at the University of Copenhagen, specializing in Gastroenterology and Hepatology under the Internal Medicine division. Her clinical and academic work is based at the Capital Region of Denmark (Region H) hospital facility located at Blegdamsvej 3 in Copenhagen, where she maintains an active research profile with 49 documented publications focusing on inflammatory bowel diseases and artificial intelligence applications in gastroenterology.

Dr. Vind's research program centers on advancing inflammatory bowel disease (IBD) management through pharmacological optimization and artificial intelligence integration. She has led clinical trials evaluating novel therapeutic regimens like the EASI trial for 5-aminosalicylate in ulcerative colitis, investigated antibiotic impacts on IBD flare-ups using Danish nationwide data, and pioneered AI tools for real-time diagnosis and endoscopic severity classification. Her work bridges clinical practice with computational approaches to improve diagnostic accuracy and treatment personalization, frequently leveraging large-scale population studies and European collaborations.

Analysis of her 2022-2025 publications reveals a strategic evolution toward AI-driven diagnostic solutions for ulcerative colitis alongside continued investigation of biologic therapies and pharmacological interventions. Her research consistently appears in high-impact gastroenterology journals, demonstrates translational clinical relevance, and influences European practice through initiatives like the I-CARE study. The interdisciplinary nature of her work connects clinical medicine with computer science to address critical gaps in IBD management.

No scientific awards or honors are documented in the available materials for Dr. Vind.

While specific details about student supervision are absent from the provided text, her extensive publication record in collaborative clinical trials and cohort studies indicates active research mentoring. Her work on multicenter projects like I-CARE and Danish nationwide studies suggests successful acquisition of competitive research funding, though specific grant mechanisms aren't detailed in the source material.

Dr. Vind operates within robust research networks including the European I-CARE Collaborator Group for biologics safety assessment and Danish nationwide consortia examining IBD treatments. Her work integrates clinical practice at Copenhagen University Hospital with academic research at the University of Copenhagen, facilitating immediate patient care improvements while contributing to long-term advances in gastroenterological science through population-based and AI-enhanced methodologies.